Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Gastrointestinal
»
Neoplasms
06. July 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 12104
Articles 1 - 20 / 242080
A retrospective study of differential prognostic factors in early-onset versus late-onset colorectal cancer: a comprehensive clinical and machine learning analysis.
PeerJ
Huang L, Zhong R, Li K, Chen J, He Y, Ye Y, Chen S, Wei Q, Mai H, Zhang Y, Wang Z.
PMID: 42405254 [PubMed - in process]
Intratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer.
Front Cell Infect Microbiol
Wang Y, Wu J.
PMID: 42404769 [PubMed - in process]
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial.
ESMO Gastrointest Oncol
El Kaddissi A, Vienot A, Fumet JD, Meurisse A, Nguyen T, Klajer E, Bouard A, Spehner L, Fein F, Stouvenot M, Dochy E, Rebucci-Peixoto M, Almotlak H, Henriquez J, Selmani Z, Vernerey D, Hervouet E, Folletet A, Kim S, Ghiringhelli F, Borg C.
PMID: 42404549 [PubMed - in process]
Comparative Evaluation of Serum Peroxiredoxin 2 (PRDX2), Serum Peroxiredoxin 4 (PRDX4), and Plasma Methylated Septin 9 (mSEPT9) Levels Against Conventional Biomarkers for Early Detection of Colorectal Cancer: A Study Protocol.
Cureus
Kellellu CK, Ray S, Tiwari R.
PMID: 42404326 [PubMed - in process]
Microbiome-derived cancer: the catabolism of bilirubin to urobilin in the liver-gut axis and its consequences.
Gastroenterol Rep (Oxf)
Davis JM, Ogbewekon A, Gordon DM, Kipp ZA, Martinez GJ, Stefater-Richards MA, Wagner KH, Hinds TD Jr.
PMID: 42404236 [PubMed - in process]
Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma.
Front Oncol
Su H, Zhao X, Qin X, Zhou X, Li M, Tian L.
PMID: 42404229 [PubMed - in process]
Antibody-drug conjugates in colorectal cancer: current landscape and future perspectives from clinical trials.
Front Oncol
Li J, Xu Y, Wang L, Zhu Y, Deng B.
PMID: 42404225 [PubMed - in process]
Prehabilitation in patients with low physical fitness undergoing colorectal cancer surgery: a scoping review.
BJA Open
Botting N, Gonçalves AC, Leckie T, Wheelwright S, Harding S, Koulouglioti C, Hodgson L.
PMID: 42404093 [PubMed - in process]
Indocyanine Green-Guided Lateral Pelvic Sentinel Lymph Node Mapping in Low Rectal Cancer: Toward a Selective Alternative to Systematic Sidewall Lymphadenectomy.
Cureus
Misca MC, Petrea SV, Catrina E, Aldoescu S, Brezean I.
PMID: 42403785 [PubMed]
Integrative management of gastric cardia cancer and precancerous lesions: prospects and mechanistic rationale for Banxia Xiexin Tang.
Front Pharmacol
Liang X, Yang L, Zhang Y, Yuan S, Hong Y.
PMID: 42403714 [PubMed]
B vitamins intake and cancer risk: a structured narrative review of evidence on riboflavin, pyridoxine, cobalamin and folate.
Pathol Oncol Res
Bertuccioli A, Palazzi CM, Massaro IA, Cazzaniga M, Cavecchia I, Matera MR, Biagioli V, Imperatori L, Di Pierro F, Belli A.
PMID: 42403423 [PubMed - indexed for MEDLINE]
Rectal Cancer Surgery in Nonagenarians: A Multi-Institutional Study of Feasibility and Risk-Stratified Outcomes.
World J Surg
Yoshida R, Teraishi F, Takanaga S, Mitsuhashi T, Inada R, Toshima T, Ohtani T, Hori N, Shigemitsu K, Yamamoto S, Kubota T, Okano Y, Nobuhisa T, Taniguchi F, Ishikawa W, Matsuda T, Umeoka T, Shoji R, Fujiwara T.
PMID: 42403346 [PubMed - as supplied by publisher]
Association of the PD-L1 CPS With the Efficacy of First-Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer.
Cancer Med
Ogura N, Ohnishi M, Inamoto R, Kito Y, Nagashima K, Takahashi N, Furuta M, Shoji H.
PMID: 42403275 [PubMed - indexed for MEDLINE]
Causal effects of blood and urinary biomarkers on cancer risk: A Mendelian randomization study.
J Int Med Res
Leng L, Li Y.
PMID: 42403162 [PubMed - indexed for MEDLINE]
Liquid biopsy for colorectal cancer screening: chances and challenges.
Intest Res
Choi HI, Cha JM.
PMID: 42403089 [PubMed - as supplied by publisher]
Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.
Cancer
Arena L, Alizai Q, Elemosho A, Chatzipanagiotou OP, Pawlik TM.
PMID: 42403041 [PubMed - indexed for MEDLINE]
The Relation Between Antibiotic Use and Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.
J Biochem Mol Toxicol
Wang Y, Jin S, Xu L, Yan C.
PMID: 42402956 [PubMed - indexed for MEDLINE]
Prognostic impact of anal cancer morphology on survival and local recurrence: A 20-year regional cohort study.
Colorectal Dis
Puthiyakunnel Saji A, Rackley T, Horwood J, Hargest R.
PMID: 42402758 [PubMed - indexed for MEDLINE]
Architectural patterns of growth of colon adenocarcinoma - comparative study.
Rom J Morphol Embryol
Martin L, Mit, Ple, Mirea CS, Erchid A, Lazarovici AR, Ciob.
PMID: 42402743 [PubMed - indexed for MEDLINE]
Ileal neuroendocrine tumors: clinicopathological features and associations with systemic inflammatory and nutritional markers.
Rom J Morphol Embryol
M, , Mogo, Mogoant, Vasile L, Cercelaru L, Barbu LA.
PMID: 42402742 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 242080
Page 1 of 12104
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy